[ad_1]
Truvada, a preventive anti-HIV treatment manufactured by the American Gilead, is insufficiently used in France by homobaduals and people born in countries of sub-Saharan Africa, which constitute the majority of the people infected every year in France, according to a report of Igas made public Monday.
This means of prevention called pre-exposure prophylaxis ( Prep) is the subject of a poster campaign by the badociation Aides
This mission report inspectors Gilles Duhamel and Aquilino Morelle of the General Inspectorate of Social Affairs (Igas), revealed by the daily Le World, points a duration of instruction of the temporary recommendation of use (RTU) of Truvada "abnormally long".
A delay that resulted in "contaminations that could have been avoided" that would be "about 350 taking into account a gradual increase in load of the device," says the Igas in a statement.
"In contrast, the provision of Truvada" via the temporary recommendation (RTU) "allowed France to earn 7.5 months compared to the European marketing authorization (AMM) and to avoid between 600 and 1,500 infections with HIV, "adds Igas.
Igas," despite the highly documented and detailed nature of this report, "deems" regrettable the virulent tone sometimes used by his as well as some excessive language ", while remaining" strongly committed to the transparency of its work and the independence of its inspectors. "
The implementation of the temporary recommendation of the preventive Truvada" was proceeded satisfactorily ". This temporary recommendation ended on 1 March 2017, with the extension of the marketing authorization for this product for prevention.
The inspectors nevertheless point out "a double inequality in access to treatment: territorial inequality (for the benefit of metropolitan urban areas) and insufficient recourse among men who have bad with men (MSM) and those born in heavily affected countries, mainly in Sub-Saharan Africa, which constitute the vast majority of the some 6.000 new infections each year
– "Accumulated delay" –
"Particular attention must be paid to the extremely worrying situation in Guyana", they add.
The implementation of this measure of PREP intervened three years after the badociation Aides had seized the Agence du Médicale (ANSM), and three and a half years after the authorization of this trait. Preventive action in the United States, on July 16, 2012.
The inspectors are developing scenarios evoking the number of contaminations avoided thanks to the advance of France in Europe or on the contrary "several hundred" or several thousand that could have avoided if the decision process had been faster.
They thus evoke "a number of contaminations consecutive to the accumulated delay" being then "between 1.666 and 4.000". An estimate based on a hypothesis – of which they have "not had the possibility to verify the bases", they specify – of the general direction of the health which estimated that "the number of contaminations avoided (thanks to the Prep) would be potentially from 1,000 to 2,400 per year. "
" France was the first country in Europe to effectively use Truvada as a precautionary measure from January 2016 ", AFP stresses. Dr. Dominique Martin, Director General of the Agence du médicament
"This (last) evaluation of Igas is an absurd paradox compared to reality, since we intervened before other European countries", s (19659003) In fact, "the Prep is still little used – by only 6% of the people concerned, according to the data available to us" he says noting that the estimates of the DGS of 2015 are "better than today".
Source link
